logo-loader
HealthCannabis
Canopy Growth Corporation

Canopy Growth Corporation splashes $165M on German vape maker

The swoop for Storz & Bickel fits with Canopy’s strategy

cannabis vape
The transaction leaves Canopy “well positioned” for the next wave of federally-regulated products, chairman Bruce Linton said

Canopy Growth Corporation (TSE:WEED) (NYSE:CGC) is splashing some of its estimated US$4 billion cash pile on a vape designer and manufacturer.

The giant of the cannabis industry is paying US$165 million (€145 million) for Germany’s Storz & Bickel, with chairman Bruce Linton calling the deal a “marquee acquisition”.

READ: Canopy Growth completes strategic extract supply agreement with MediPharm Labs

He added that the transaction leaves Canopy “well positioned” for the next wave of federally-regulated products in Canada beyond dried flower and edible oils.

“By combining [our] existing designs and Canada's open environment for federally permissible R&D with Storz & Bickel's deep IP portfolio and management team, Canopy Growth is poised to lead the high-margin vaporizing category around the world," Linton explained.

Storz founder Jürgen Bickel will remain with the business.

Swoop fits with strategy

The swoop for S&B fits with Canopy’s strategy, which is to be a “category killer” in the international market for cannabis products.

It sells a wide range of products including the dried plant, oils and capsules for both medical and recreational use.

In August, the beer and spirits group Constellation Brands made a US$3.7 billion (C$5 billion) investment in the business and the two firms are currently working on a cannabis-infused beer.

The global market for medical cannabis is forecast to generate US$180 billion within the next few years.

In 11 countries

Canopy has a presence in 11 countries, including Australia, Germany and Spain.

Most have already legalized cannabis for medical use or are on the cusp of doing so.

Noteworthy is the fact that, while Canopy’s shares are listed in New York, the firm does not conduct business in the United States where cannabis possession is still a federal status.

Quick facts: Canopy Growth Corporation

Price: $37.72

Market: TSX
Market Cap: $13.12 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Lexagene Develops technology to test for deadly mosquito...

Lexagene (CVE: LXG-OTCQB-LXXGF) Founder and CEO Dr jack Regan joined Steve Darling from Proactive Vancouver on Skype with news the company has used their proprietary technology to develop a detection system for the Eastern Equine Encephalitis or EEE. Regan says that not only can they use the...

13 minutes ago

2 min read